NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
PIK3CA mutated HER2+ advanced or relapsed breast cancer (BC) previously treated with trastuzumab
1 total trials
Filter these 1 trials by phase, country, sponsor and more.